BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20336417)

  • 21. Development of human calcitonin gene-related peptide (CGRP) receptor antagonists. 1. Potent and selective small molecule CGRP antagonists. 1-[N2-[3,5-dibromo-N-[[4-(3,4-dihydro-2(1H)-oxoquinazolin-3-yl)-1-piperidinyl]carbonyl]-D-tyrosyl]-l-lysyl]-4-(4-pyridinyl)piperazine: the first CGRP antagonist for clinical trials in acute migraine.
    Rudolf K; Eberlein W; Engel W; Pieper H; Entzeroth M; Hallermayer G; Doods H
    J Med Chem; 2005 Sep; 48(19):5921-31. PubMed ID: 16161996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of a serotonin agonist (sumatriptan) on the peptidergic innervation of the rat cerebral dura mater and on the expression of c-fos in the caudal trigeminal nucleus in an experimental migraine model.
    Knyihár-Csillik E; Tajti J; Samsam M; Sáry G; Slezák S; Vécsei L
    J Neurosci Res; 1997 Jun; 48(5):449-64. PubMed ID: 9185668
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recent advances in understanding migraine mechanisms, molecules and therapeutics.
    Goadsby PJ
    Trends Mol Med; 2007 Jan; 13(1):39-44. PubMed ID: 17141570
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal complexity is attenuated in preclinical models of migraine and restored by HDAC6 inhibition.
    Bertels Z; Singh H; Dripps I; Siegersma K; Tipton AF; Witkowski WD; Sheets Z; Shah P; Conway C; Mangutov E; Ao M; Petukhova V; Karumudi B; Petukhov PA; Baca SM; Rasenick MM; Pradhan AA
    Elife; 2021 Apr; 10():. PubMed ID: 33856345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of the brainstem in migraine: Potential brainstem effects of CGRP and CGRP receptor activation in animal models.
    Holland PR; Saengjaroentham C; Vila-Pueyo M
    Cephalalgia; 2019 Mar; 39(3):390-402. PubMed ID: 29411638
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
    Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
    Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of capsaicin-induced meningeal neurogenic sensory vasodilatation in diabetic rats.
    Dux M; Rosta J; Pintér S; Sántha P; Jancsó G
    Neuroscience; 2007 Nov; 150(1):194-201. PubMed ID: 17920775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Calcitonin gene-related peptide and substance P regulate the intestinal radiation response.
    Wang J; Qiu X; Kulkarni A; Hauer-Jensen M
    Clin Cancer Res; 2006 Jul; 12(13):4112-8. PubMed ID: 16818712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elevated saliva calcitonin gene-related peptide levels during acute migraine predict therapeutic response to rizatriptan.
    Cady RK; Vause CV; Ho TW; Bigal ME; Durham PL
    Headache; 2009 Oct; 49(9):1258-66. PubMed ID: 19788468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colocalization of 5-HT1F receptor and calcitonin gene-related peptide in rat vestibular nuclei.
    Ahn SK; Khalmuratova R; Jeon SY; Kim JP; Park JJ; Hur DG; Balaban CD
    Neurosci Lett; 2009 Nov; 465(2):151-6. PubMed ID: 19735698
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sex-related differences in animal models of migraine headache.
    Bolay H; Berman NE; Akcali D
    Headache; 2011 Jun; 51(6):891-904. PubMed ID: 21631475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Female sex hormones and rat dural vasodilatation to CGRP, periarterial electrical stimulation and capsaicin.
    Gupta S; Villalón CM; Mehrotra S; de Vries R; Garrelds IM; Saxena PR; MaassenVanDenbrink A
    Headache; 2007 Feb; 47(2):225-35. PubMed ID: 17300362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unilateral injection of calcitonin gene-related peptide (CGRP) induces bilateral oedema formation and release of CGRP-like immunoreactivity in the rat hindpaw.
    Bileviciute I; Stenfors C; Theodorsson E; Lundeberg T
    Br J Pharmacol; 1998 Nov; 125(6):1304-12. PubMed ID: 9863661
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suppression of cortical spreading depression in migraine prophylaxis.
    Ayata C; Jin H; Kudo C; Dalkara T; Moskowitz MA
    Ann Neurol; 2006 Apr; 59(4):652-61. PubMed ID: 16450381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CGRP antagonists: unravelling the role of CGRP in migraine.
    Doods H; Arndt K; Rudolf K; Just S
    Trends Pharmacol Sci; 2007 Nov; 28(11):580-7. PubMed ID: 17963849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inflammation and excitotoxicity: role in migraine pathogenesis.
    Longoni M; Ferrarese C
    Neurol Sci; 2006 May; 27 Suppl 2():S107-10. PubMed ID: 16688611
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Female sex steroid hormones and pregnancy regulate receptors for calcitonin gene-related peptide in rat mesenteric arteries, but not in aorta.
    Yallampalli C; Kondapaka SB; Lanlua P; Wimalawansa SJ; Gangula PR
    Biol Reprod; 2004 Apr; 70(4):1055-62. PubMed ID: 14668209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcitonin gene-related peptide does not interact with sympathetic activity in myocardial ischemia.
    Burgdorf C; Dendorfer A; Kurz T; Richardt G
    Regul Pept; 2005 Feb; 125(1-3):99-102. PubMed ID: 15582720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of the prototype serotonin 5-HT(1B/1D) receptor agonist sumatriptan and the calcitonin gene-related peptide (CGRP) receptor antagonist CGRP(8-37) on myocardial reactive hyperemic response in conscious dogs.
    Lynch JJ; Shen YT; Pittman TJ; Anderson KD; Koblan KS; Gould RJ; Regan CP; Kane SA
    Eur J Pharmacol; 2009 Nov; 623(1-3):96-102. PubMed ID: 19766109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evidence for orexinergic mechanisms in migraine.
    Hoffmann J; Supronsinchai W; Akerman S; Andreou AP; Winrow CJ; Renger J; Hargreaves R; Goadsby PJ
    Neurobiol Dis; 2015 Feb; 74():137-43. PubMed ID: 25447225
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.